Pharma, Biotech & AI
Novartis
A searchable company profile that connects brand discovery with related news, official links, and the Life AI Net directory.
Latest related news
Jun 12, 2026 Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win - BioSpace
View all 80 articles Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win BioSpace
Jun 11, 2026 Muscular dystrophy siRNA from Novartis' buyout of Avidity meets biomarker endpoints - FirstWord PharmaMuscular dystrophy siRNA from Novartis' buyout of Avidity meets biomarker endpoints FirstWord Pharma
Jun 11, 2026 Novartis RNA drug acquired in $12B Avidity deal notches a trial win - BioPharma DiveNovartis RNA drug acquired in $12B Avidity deal notches a trial win BioPharma Dive
Jun 11, 2026 Novartis gets win for another Avidity muscular dystrophy AOC - pharmaphorumNovartis gets win for another Avidity muscular dystrophy AOC pharmaphorum
Jun 11, 2026 Novartis $12bn bet on Avidity well placed after mid-stage FSHD win - Clinical Trials ArenaNovartis $12bn bet on Avidity well placed after mid-stage FSHD win Clinical Trials Arena
Jun 10, 2026 Novartis sticks 2nd deal with molecular glue biotech Orionis, this one worth up to $1.4B - Fierce BiotechNovartis sticks 2nd deal with molecular glue biotech Orionis, this one worth up to $1.4B Fierce Biotech
Data signals
- Category: Pharma, Biotech & AI
- External sources: 1
- Website: verified